Mednet Logo
SpecialtiesRheumatology
Rheumatology

Rheumatology

Clinical discussions on autoimmune diseases, biologic therapies, vasculitis, and musculoskeletal conditions.

Recent Discussions

How do you manage worsening cutaneous dermatomyositis when muscle disease appears controlled?

3
3 Answers

Mednet Member
Mednet Member
Rheumatology · The University of Texas Health Science Center at Houston (UTHealth)

The fact that the patient still has an active pruritic rash while tapering steroids suggests that the current regimen isn't fully controlling the disease, and it can affect quality of life. I would consider adjusting immunosuppression, either adding another agent or switching therapies. The specific...

Do you taper glucocorticoids less aggressively when symptoms improve but serologies remain active in a patient with non-renal SLE?

2
3 Answers

Mednet Member
Mednet Member
Rheumatology · Duke University Medical Center

Cautious tapering of glucocorticoids is a good idea in the setting of ongoing serologic activity. However, given there is clinical improvement in symptoms, one can go ahead and proceed with tapering steroids. It is important to recognize that a subset of patients with SLE may have persistent abnorma...

Which serologic tests are most helpful when evaluating for suspected drug-induced lupus?

3
2 Answers

Mednet Member
Mednet Member
Dermatology · Stanford University School of Medicine

If I suspect drug-induced lupus, I typically order the following laboratory testing: ANA/IFA Anti-histone antibody, usually positive in drug-induced lupus Anti-Ro antibody, usually positive in drug-induced subacute cutaneous lupus Anti-dsDNA, usually negative in drug-induced lupus vs positive in id...

Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?

2
2 Answers

Mednet Member
Mednet Member
Rheumatology · Virginia Commonwealth University

Yes, I think patients starting Cyclophosphamide should be screened routinely for latent TB since CYC is a strong immunosuppressant and increases the risk of TB reactivation. The issue is that CYC is often being considered for life or organ-threatening situations, for which it may not be ideal to wai...

Do you always perform salivary gland biopsy to confirm the diagnosis In patients with suspected seronegative Sjogren's syndrome?

4
2 Answers

Mednet Member
Mednet Member
Rheumatology · Tristate Arthritis & Rheumatology

I often struggle with the decision of obtaining a biopsy in suspected Sjogren's in a person who is seronegative, when the main issue is dryness, and the main reason is that I wonder if it will make a difference in management. When I was a Rheumatology fellow, I was taught to give Hydroxychloroquine ...

Should tuberculosis screening be performed before beginning methotrexate for treatment of rheumatoid arthritis?

1
1 Answers

Mednet Member
Mednet Member
Rheumatology · Cleveland Clinic

While it is not recommended or required to screen for latent TB (LTBI) prior to starting methotrexate, for many patients this may serve as a good opportunity to screen for LTBI, as many patients will go on to require biologic therapy due to incomplete response to methotrexate. There are many limitat...

Do you ever consider tapering off steroid-sparing agents in patients with stable non-IPF ILD?

4
2 Answers

Mednet Member
Mednet Member
Pulmonology · Massachusetts General Hospital

In short, the answer is YES—I always look for ways to reduce immunosuppression exposure over time and use the lowest effective dose required to keep a patient’s inflammatory ILD in check. I often remind myself that when these patients present with a mixture of fibrotic changes (e.g., traction bronch...

Would you be comfortable combining rituximab with voclosporin in patients with lupus nephritis not responding to standard therapy?

2 Answers

Mednet Member
Mednet Member
Rheumatology · Uniformed Services University of the Health Sciences (USUHS)

1st: Voclosporin is standard therapy :-). I find it interesting that we often use "standard therapy" to mean "a mycophenolate analogue or cyclophosphamide (CYC)." I consider these "old therapies" that only achieve a 25% to 30% clinical remission, leaving 65% - 70% of those patients at high risk of e...

What were your top takeaways in Myositis from ACR Convergence 2025?

1
2 Answers

Mednet Member
Mednet Member
Rheumatology · Emory University

ACR Convergence had an outstanding selection of myositis offerings, and the number of people attending the sessions reflects the increasing recognition of these heterogeneous diseases, coupled with the frequency that non-myositis specialist clinicians will encounter these entities. The convention pr...

How often do you draw screening ANAs for discoid lupus?

2 Answers

Mednet Member
Mednet Member
Rheumatology · Harvard Medical School

Because a positive ANA is associated with an increased risk of progression to SLE in patients with discoid lupus, I routinely check an ANA at the initial visit in virtually all patients. If negative, I repeat it only if new symptoms concerning systemic involvement arise (e.g., joint pain, cytopenias...